425 results on '"Marche, Patrice N"'
Search Results
2. SAT-389 HBV and HBsAg strongly reshape the phenotype, function and metabolism of DCs according to patients’ clinical stage
3. SAT-396 Differences in the intrahepatic expression of immune checkpoint molecules on T cells and natural killer cells in chronic HBV patients
4. Synthesis and use of an amphiphilic dendrimer for siRNA delivery into primary immune cells
5. Enjeux actuels autour des thérapies combinées de carcinome hépatocellulaire : immunomodulations et vaccins.
6. From secretome analysis to immunology: chitosan induces major alterations in the activation of dendritic cells via a TLR4-dependent mechanism
7. Data from Efficacy of AKT Inhibitor ARQ 092 Compared with Sorafenib in a Cirrhotic Rat Model with Hepatocellular Carcinoma
8. Supplementary Material and Method, Supplementary Tables 1-2, and Figure Legends from Efficacy of AKT Inhibitor ARQ 092 Compared with Sorafenib in a Cirrhotic Rat Model with Hepatocellular Carcinoma
9. Figure S4 from Efficacy of AKT Inhibitor ARQ 092 Compared with Sorafenib in a Cirrhotic Rat Model with Hepatocellular Carcinoma
10. Tailoring nanostructured lipid carriers for the delivery of protein antigens: Physicochemical properties versus immunogenicity studies
11. Impact of silica nanoparticle surface chemistry on protein corona formation and consequential interactions with biological cells
12. Immune checkpoints on T and NK cells in the context of HBV infection: Landscape, pathophysiology and therapeutic exploitation
13. Immunologic Features of Patients With Advanced Hepatocellular Carcinoma Before and During Sorafenib or Anti-programmed Death-1/Programmed Death-L1 Treatment
14. Overcoming immunogenicity issues of HIV p24 antigen by the use of innovative nanostructured lipid carriers as delivery systems: evidences in mice and non-human primates
15. Effect of Novel AKT Inhibitor Vevorisertib as Single Agent and in Combination with Sorafenib on Hepatocellular Carcinoma in a Cirrhotic Rat Model
16. Enantioselective Approach for Expanding the Three‐Dimensional Space of Tetrahydroquinoline to Develop BET Bromodomain Inhibitors**
17. Lymphocytes Degranulation in Liver in Hepatitis C Virus Carriers Is Associated With IFNL4 Polymorphisms and ALT Levels
18. Polymer adhesive surface as flexible generic platform for multiplexed assays biochip production
19. Relationship between humoral response against hepatitis C virus and disease overcome
20. Increased Intrahepatic Expression of Immune Checkpoint Molecules in Autoimmune Liver Disease
21. Biosensor for direct cell detection, quantification and analysis
22. Increased Intrahepatic Expression of Immune Checkpoint Molecules in Autoimmune Liver Disease
23. DEN-Induced Rat Model Reproduces Key Features of Human Hepatocellular Carcinoma
24. Liver-infiltrating CD8+ lymphocytes as prognostic factor for tumour recurrence in hepatitis C virus-related hepatocellular carcinoma
25. Peptide–protein microarrays and surface plasmon resonance detection: Biosensors for versatile biomolecular interaction analysis
26. Tuning the Immunostimulation Properties of Cationic Lipid Nanocarriers for Nucleic Acid Delivery
27. Therapeutic siRNAs Targeting the JAK/STAT Signalling Pathway in Inflammatory Bowel Diseases
28. A Lymphotoxin-Driven Pathway to Hepatocellular Carcinoma
29. Structure of a Third Murine Immunoglobulin λ Light Chain Variable Region that is Expressed in Laboratory Mice
30. V β 17 T-Cell Deletion by Endogeneous Mammary Tumor Virus in Wild- Type-Derived Mouse Strain
31. Nucleic acid-mediated tuning of charge: A strategy to dampen the immunotoxic effect of cationic lipid nanocarriers
32. Tuning the immunostimulation properties of cationic lipid nanocarriers for nucleic acid delivery
33. Contactless Bio‐Electrofunctionalization of Planar Micropores
34. Modeling Diet-Induced NAFLD and NASH in Rats: A Comprehensive Review
35. Enhanced susceptibility of T lymphocytes to oxidative stress in the absence of the cellular prion protein
36. A new role for complement C3: Regulation of antigen processing through an inhibitory activity
37. Distinct effects of DNA-PKcs and Artemis inactivation on signal joint formation in vivo
38. Analysis of the toxicity of gold nano particles on the immune system: effect on dendritic cell functions
39. Targeting Akt in Hepatocellular Carcinoma and Its Tumor Microenvironment
40. Impact of Gold Nanoparticles on the Functions of Macrophages and Dendritic Cells
41. Hybrid multimodal contrast agent for multiscalein vivoinvestigation of neuroinflammation
42. C1q binding and complement activation by prions and amyloids
43. C3b complexation diversifies naturally processed T cell epitopes
44. Infection of human astrocytes and glioblastoma cells with Toxoplasma gondii: monocyte chemotactic protein-1 secretion and chemokine expression in vitro
45. Circulating IL-13 Is Associated with De Novo Development of HCC in HCV-Infected Patients Responding to Direct-Acting Antivirals
46. Synthesis and use of an amphiphilic dendrimer for siRNA delivery into primary immune cells
47. The envelope of human endogenous retrovirus in neuro-inflammation
48. Therapeutic siRNAs Targeting the JAK/STAT Signalling Pathway in Inflammatory Bowel Diseases.
49. Early thymic T cell development in young transgenic mice overexpressing human Cu/Zn superoxide dismutase, a model of Down syndrome
50. Gene-specific signal joint modifications during V(D)J recombination of TCRAD locus genes in murine and human thymocytes
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.